Trial Profile
The effects of normalising sex hormone levels in obese hypogonadal men: a prospective randomised comparator controlled parallel arm clinical trial.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Dec 2019
Price :
$35
*
At a glance
- Drugs Letrozole (Primary) ; Testosterone undecanoate
- Indications Hypogonadism
- Focus Pharmacodynamics
- 30 Sep 2012 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials
- 16 Sep 2010 New trial record